RecruitingNot ApplicableNCT06468293
Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer
The Role of Caregiver in the Clinical Pathway of Patients Newly Diagnosed With Breast and Prostate Cancer: a Randomized Study
Sponsor
European Institute of Oncology
Enrollment
102 participants
Start Date
Oct 8, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The following randomized longitudinal study will evaluate the long term impact of caregivers' involvement in cancer care pathway, including a psychological support intervention on the dyads to be delivered after the detection of a suspected cancer and before the visit with the oncologist for discussing therapeutic options.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Patient:
- Patient aged ≥18 years at the time of recruitment.
- Patients who have just received a cancer diagnosis and have yet to discuss with their oncologist the treatment to undergo after diagnosis of breast or prostate cancer.
- Early-stage cancer (I or II).
- Caregiver:
- Age ≥ 18 at the time of recruitment.
- Taking care of the patient.
Exclusion Criteria5
- Patients:
- Presence of early mental disorders (before age 40) or severe neurological disorder.
- Patients with advanced stage cancer for which the path is already defined (palliative care patients).
- Caregivers:
- ● Presence of early mental disorders (before age 40) or severe neurological disorder.
Interventions
OTHERPsychological support
Psychological support intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06468293
Related Trials
Small Bowel Capsule Endoscopy in Lynch Syndrome
NCT074726861 location
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
NCT068355699 locations
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
NCT043337063 locations
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
NCT0653305951 locations
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
NCT070727283 locations